A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
Public ClinicalTrials.gov record NCT04492722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, Dose-Ranging Study of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
Study identification
- NCT ID
- NCT04492722
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 613 participants
Conditions and interventions
Conditions
Interventions
- AZD5718 Drug
- Dapagliflozin 10 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2020
- Primary completion
- Sep 5, 2022
- Completion
- Sep 5, 2022
- Last update posted
- Dec 19, 2024
2020 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 11
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Canoga Park | California | 91303 | — |
| Research Site | La Mesa | California | 91942 | — |
| Research Site | San Carlos | California | 94070 | — |
| Research Site | San Francisco | California | 94110 | — |
| Research Site | Victorville | California | 92392 | — |
| Research Site | Denver | Colorado | 80045 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Winter Haven | Florida | 33880 | — |
| Research Site | Columbus | Georgia | 31904 | — |
| Research Site | Roseville | Michigan | 48066 | — |
| Research Site | Hazelwood | Missouri | 63042 | — |
| Research Site | Fresh Meadows | New York | 11365 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | Jamaica | New York | 11432 | — |
| Research Site | Blue Ash | Ohio | 45242 | — |
| Research Site | East Providence | Rhode Island | 02914 | — |
| Research Site | Memphis | Tennessee | 38104-2127 | — |
| Research Site | Austin | Texas | 78738 | — |
| Research Site | Houston | Texas | 77099 | — |
| Research Site | Pearland | Texas | 77584 | — |
| Research Site | San Antonio | Texas | 78215 | — |
| Research Site | Schertz | Texas | 78154 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04492722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2024 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04492722 live on ClinicalTrials.gov.